Brello Health vs Fridays
Brello Health costs $91.28 less a month, and both sell semaglutide.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Brello Health
Best for: seeing what it charges before you answer any medical questions
Visit Brello Health →
Fridays
Best for: coaching bundled into the price rather than sold separately
Visit Fridays →If you are choosing between Brello Health and Fridays, the first difference is cost: Brello Health is $91.28 a month cheaper at the entry price. Both prescribe semaglutide, so moving from one to the other would not change your drug. Brello Health leads our six-part score, 7.4 to 5.5.
Brello Health vs Fridays price
Brello Health is the cheaper way in: $157.72 a month against $249 a month at Fridays. That is $91.28 less each month (37% lower), or about $1,095.36 over a year of treatment.
Drug by drug: Semaglutide is cheaper at Brello Health ($157.72 a month vs $249 a month).
Medications and formats
Both sell semaglutide; only Fridays lists tirzepatide.
On format, Brello Health prices compounded injections, while Fridays prices compounded injections and brand-name pens.
If you want the FDA-approved brand rather than a compounded version, Fridays is the only one of the two with a brand-name price.
Where each one treats patients
Brello Health lists 35 states, and Fridays does not publish where it ships.
Pricing
Brello Health
Fridays
What each price covers
Both prices cover the clinician visit and the medication itself.
Fridays' price also covers coaching, which Brello Health does not claim.
Brello Health is silent on shipping, lab work and coaching.
Fridays is silent on shipping and lab work.
Brello Health
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
Not stated
Lab work
Not stated
Coaching
Not stated
Fridays
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
Not stated
Lab work
Not stated
Coaching
In the price
Where each one scores higher
Overall, Brello Health scores 7.4 and Fridays 5.5 out of 10.
Brello Health is stronger on value (6.1 vs 2.8), user experience (8.0 vs 3.0), trust & safety (8.5 vs 4.0) and accessibility (7.6 vs 5.0).
Fridays is stronger on effectiveness (10.0 vs 8.5) and support (7.0 vs 5.5).
Brello Health
7.4/10
Fridays
5.5/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
FDA warning letters
Neither Brello Health nor Fridays has an FDA warning letter on record with us.
Features & Coverage
| Feature | Brello Health | Fridays |
|---|---|---|
| Starting Price | ✓$157.72/mo | $249/mo |
| Features | 2 features | 2 features |
| States Available | 35 | Not disclosed |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | — | ✓ Yes |
| FSA/HSA Accepted | — | — |
| FDA Warning Letters | None | None |
About Brello Health
Brello Health is a telehealth wellness platform selling GLP-1 weight management.
Read our full Brello Health review →About Fridays
Fridays is a telehealth weight loss seller running compounded GLP-1 programs.
Read our full Fridays review →Pros & Cons
Brello Health
What we like
- Semaglutide costs $157.72 a month, 14% below the $184 median for compounded semaglutide across the sellers we compare
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes the medication and clinician visits
- We found no FDA warning letters issued to Brello Health
Watch-outs
- Serves only 35 states, so check that yours is one of them
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide is compounded rather than FDA-approved, so it has not been reviewed by the agency for safety, effectiveness or manufacturing quality
Fridays
What we like
- The monthly price includes the medication, clinician visits and coaching
- We found no FDA warning letters issued to Fridays
Watch-outs
- Semaglutide costs $249 a month, 35% above the $184 median for compounded semaglutide across the sellers we compare
- Tirzepatide costs $359 a month, 44% above the $250 median for compounded tirzepatide across the sellers we compare
- You only see a price after finishing the medical intake, so you cannot compare costs before sharing health information
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Our Verdict
Brello Health wins this one, 7.4 to 5.5, above all for seeing what it charges before you answer any medical questions. It also costs $91.28 less each month than Fridays. Fridays fits better if coaching bundled into the price rather than sold separately is your priority.
Choose Brello Health if…
You want seeing what it charges before you answer any medical questions and an opening price near $157.72 a month.
Choose Fridays if…
You want coaching bundled into the price rather than sold separately and an opening price near $249 a month.
Ready to start? GLP-1 providers we have vetted
Telehealth providers, vetted by us, prescribing GLP-1 online.
Vetted by our editors · no insurance required
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
RNK Health
An oral route if you will not self-inject
From $197/mo
Get started →He & She MD
Starting below a standard dose, with microdose tiers
From $99/mo
Get started →Wellorithm
Compounded semaglutide at $247/month
From $247/mo
Get started →Brello Health vs Fridays: FAQ
Close alternatives to Brello Health and Fridays
- Brello Health vs AM Rx
- Brello Health vs FitRx
- Brello Health vs SynergenX Health
- Brello Health vs Dr. Gillis' Wellness Center
- Fridays vs Luvo Health
- Fridays vs RxSpan MD
Or see the full category ranking.
Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.